Clinical characteristics, management and outcomes of patients with Recurrence after therapeutic PK (Refer to Table 2)
Case no. | Age/gender | Site of initial recurrence | Time interval between Th PK and recurrence | Donor graft size (mm) | Clinical Course on medical therapy (natamycin 1 h and oral Azoles) | Surgical intervention for recurrence | Microbiology characteristics (smear+/- culture) | Final outcome |
---|---|---|---|---|---|---|---|---|
1 | 46/m | GHJ | 27 days | 9.5 | Resolved on medical therapy | Nil | Fungus filaments | Anatomical restoration, BCVA -20/200 at 4 months |
2 | 36/m | GHJ | 7 days | 12 | Rapid spread to posterior segment (Endophthalmitis) | Evisceration | Fungus filaments | Anophthalmos |
3 | 40/f | AC | 13 days | 9 | Lost to follow up after recurrence noted, patient reviewed at 2 months later | Nil | Not available | Phthisis (noted at 2 months) |
4 | 35/m | GHJ + AC | 6 days | 11.5 | Resolved on medical therapy | AC wash + intracameral injection of amphotericin B | Fungus filaments | Phthisis |
5 | 30/f | GHJ + AC | 24 days | 11.5 | No response to medical therapy | Repeat ThPK | Acremonium species | Clear repeat graft, BCVA 20/50 at 2 months |
6 | 77/m | AC | 22 days | 11 | Resolved on medical therapy | AC wash | Dematiaceous fungus | Clear graft, with BCVA -20/800 at 2 months |
7 | 50/f | GHJ | 25 days | 9.5 | No response | Repeat ThPk | Fusarium species | BCVA 20/1200 at 1 month |
8 | 22/f | AC | 6 days | 11.5 | Slow response | AC wash + intracameral injection of amphotericin B | Fungal filaments | Edematous graft with BCVA HM at 5 months |
9 | 60/m | AC | 25 days | 9.5 | Slow response | AC wash + intracameral injection of amphotericin B | Fungal filaments | Clinical cure, BCVA HM at 1 month |
10 | 35/m | AC | 6 days | 9 | Slow response | ECCE + AV + AC reformation + intracameral amphoptericin-B | Fungal filaments | Failed graft |
11 | 48/m | GHJ + AC + PS | 28 days | 10 | Slow response | TA BCL + AC wash + intravitreal amphotericin B | Fungal filaments | Phthisis at 1 month |
12 | 35/f | GHJ + AC | 14 days | 8.5 | Resolved on medical therapy | Nil | Fungal filaments | Edematous graft, HM at 2 months |
13 | 45/f | AC + PS | 1 day | 8.5 | Posterior segment spread (Endophthalmitis) | PPV + IOAB + Intravitreal Ampho B | Not available | Phthisis |
14 | 45/f | AC + PS | 11 days | 11 | Posterior segment spread (Endophthalmitis) | Evisceration | Fungal filaments | Anophthalmos |
15 | 50/f | AC + PS | 11 days | 12 | Posterior segment spread (Endophthalmitis) | PPV + IOAB + Intravitreal Ampho B, Evisceration | Not available | Anophthalmos |
16 | 40/m | AC | 5 days | 9.5 | Partial response | AC wash + intracameral injection of amphotericin B | Not available | Failed graft at 3 months |
17 | 35/f | AC | 6 days | 12 | Partial response | AC wash + intracameral injection of amphotericin B | Fungus filaments | Failed graft at 2 months |
18 | 35/m | GHJ + AC | 14 days | 10.5 | Partial response | Repeat ThPK | Aspergillus flavus | Edematous graft, BCVA 20/600 at 6 months |
19 | 50/m | GHJ | 7 days | 8.75 | Resolved on medical treatment | Nil | Fungal filaments | BCVA 20/125 at 1 month |
20 | 43/m | GHJ | 25 days | 11.5 | Partial response | Repeat ThPK | Aspergillus flavus | Clear Repeat graft, BCVA 20/80 at 2 months |